Do I need regular blood tests while using Adagrasib?

Adagrasib is an oral targeted therapy drug targeting KRAS G12C mutations. It is mainly used to treat patients with solid tumors such as non-small cell lung cancer who suffer from such gene mutations. As a small molecule targeted inhibitor, while exerting anti-tumor effects, adagrasib may also have a certain impact on patients' liver function, blood cell counts, etc. Therefore, regular blood tests during treatment are very important for monitoring.

First of all, adagrasib may cause liver function abnormalities, such as elevated transaminases (ALT, AST) or elevated bilirubin levels. If not monitored in time, it may lead to liver damage or even drug-induced hepatitis. Therefore, it is recommended that patients test their liver function every two weeks in the initial stage of medication, and then adjust it to once a month according to the situation, and conduct liver function tests immediately when symptoms such as fatigue, loss of appetite, and yellowing of the skin occur.

Secondly, adagrasib may also affect the blood system, such as causing a decrease in white blood cells, neutrophils or platelets, which may increase the risk of infection and bleeding. Regular complete blood count (CBC) examinations can help early detection and management of these potential adverse reactions. Especially when used in combination with other drugs, changes in blood indicators need to be closely monitored.

Finally, patients who use adagrasib for a long time also need to pay attention to electrolyte balance, renal function and heart-related indicators. Studies have shown that some patients may develop electrolyte abnormalities or electrocardiogram abnormalities such as prolonged QT interval during treatment. Therefore, doctors usually develop a personalized blood test plan based on the patient's specific situation to ensure the safety and continuity of treatment. Patients should actively cooperate, draw blood for review on time, and maintain close communication with their doctors.

Reference materials:https://www.drugs.com/